MAP3K2 and colonic neoplasm: To validate the predicted MAP3K2 that was actually suppressed by miR-372-3p in colon cancer cells, we constructed two luciferase reporter plasmids containing the miR-372-3p target sites (264–270 and 6552–6558) in the MAP3K2 3′-UTR region (Figure 5F).